StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
GENI.ST$39.60-1.24%
Fair $39.60+0.0%

GENI.ST

Generic Sweden AB

Technology / Software - ApplicationStockholm

$39.60

-0.50 (-1.24%)

Fairly Valued+0.0%Fair Value $39.60Fund rank 32/100 · Data gapFallback financials|
SA 47/C
F-Score: 4/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 24% · confianza 25%

FCF escenarios

weak_data · normalized FCF $21.9M · quality 61.7/100

Data gap 32/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 77/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

47/100

C

Piotroski

4/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · GENI.STLocal privado en este navegador · Generic Sweden AB
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$487M

P/E

15.7x

↓

EV/EBITDA

10.6x

↓

ROE

46.6%

↑

Gross Margin

38.1%

↑

Debt/Equity

N/A

•
52-Week Range$40
$34$63

TradingView lightweight chart

GENI.ST price, volumen y niveles de valoración

Último $39.75Periodo +541.1%
Fair value: $39.60

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+12.9%

FCF CAGR

+39.2%

FCF margin

20.3%

FCF / Net income

1.20x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $183.7M · net income $31.0M · FCF $37.3M

2022-FY → 2025-FY

Gross margin

38.1%+2.5% pts

Operating margin

21.5%+1.4% pts

Net margin

16.9%+0.9% pts

FCF margin

20.3%+9.5% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$183.7M$183.7M$176.4M$142.6M$127.7M
Net Income$31.0M$31.0M$27.3M$23.3M$20.4M
EBITDA$40.3M$40.3M$35.5M$30.2M$26.9M
EPS——2.221.901.66
Gross Margin38.1%38.1%32.8%34.6%35.6%
Operating Margin21.5%21.5%19.3%20.1%20.2%
Net Margin16.9%16.9%15.4%16.3%16.0%
Balance Sheet
Current Ratio3.333.33———
Cash Flow
Free Cash Flow$37.3M$37.3M$21.9M$20.0M$13.8M
Returns
ROE46.6%46.6%49.3%50.2%53.2%
Valuation
P/E15.7115.7125.8627.1621.08
EV/EBITDA10.6310.6318.6920.1614.80
P/B7.317.3112.7613.6411.21
Growth & Yield
Revenue Growth4.1%4.1%23.7%11.6%—
EPS Growth——16.8%14.5%—
Dividend Yield4.4%4.4%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -31.1%

Total return

-31.1%

Start / end P/E

n/dx → n/dx

EPS bridge

2.22 → n/d

Residual

-35.5%

EPS growthn/d
Multiple reratingn/d
Dividend+4.4%
Residual / FX / buybacks / cross-term-35.5%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.